The assessment of OPG levels revealed that this protein was significantly higher in MVP patients when compared to controls (1748 ± 100.2 versus 1109 ± 45.3 pg/mL, respectively; p < 0.0001, Figure 1(a)). Here, TNFRSF11B is linked to familial mitral valve prolapse.